The third quarter of 2022 saw progress in several areas, such as the construction of the laboratory facilities in Campus Solna in Stockholm, the setup of a simulation laboratory in Linköping and the recruitment of skilled personnel, including that of Dr. Claes Lindh, the company’s new Chief Medical Officer (CMO) as of September.
Some highlights of the quarter are discussed in this panel talk led by Ole Eikeland, where Lindh and Inify’s CEO Fredrik Palm share their thoughts both on the past months and the future:
https://www.youtube.com/watch?v=Wn9d1eVuT18